Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata

Obstetrics and Gynecology

Volumn 108, Issue 1, 2006, Pages 49-54

  Smart, O C ^a   Hindley, J T ^a   Regan, L ^a   Gedroyc, W G ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GOSERELIN; FERTILITY PROMOTING AGENT; GONADORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; EMERGENCY SURGERY; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SCREENING TEST; TREATMENT OUTCOME; TUMOR VOLUME; ULTRASOUND THERAPY; UTERUS MYOMA; LEIOMYOMATOSIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PAIN; PATIENT SATISFACTION; PROSPECTIVE STUDY; QUALITY OF LIFE; UTERUS CANCER;

ADULT; COMBINED MODALITY THERAPY; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEIOMYOMATOSIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PAIN; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME; ULTRASONIC THERAPY; UTERINE NEOPLASMS;

EID: 33746864111     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000222381.94325.4f     Document Type: Article

References (23)

1. ter Haar G. Therapeutic ultrasound. Eur J Ultrasound 1999;9:3-9.
2. Hynynen K, Damianou C, Darkazanli A, Unger E, Schenck JF. The feasibility of using MRI to monitor and guide noninvasive ultrasound surgery. Ultrasound Med Biol 1993;19:91-2.
3. Lynn J, Zwemer R, Chick A, Miller A. A new method for the generation and use of focused ultrasound in experimental biology. J Gen Physiol 1942;26:179-93.
4. Cline HE, Hynynen K, Watkins RD, Adams WJ, Schenck JF, Ettinger RH, et al. Focused US system for MR imaging-guided tumor ablation. Radiology 1995;194:731-7.
5. Hynynen K, Pomeroy O, Smith DN, Huber PE, McDannold NJ, Kettenbach J, et al. MR imaging-guided focused ultrasound surgery of fibroadenomas in the breast: a feasibility study. Radiology 2001;219:176-85.
6. McDannold N, Moss M, Killiany R, Rosene DL, King RL, Jolesz FA, et al. MRI-guided focused ultrasound surgery in the brain: tests in a primate model. Magn Reson Med 2003;49:1188-91.
7. Jolesz FA, Hynynen K, McDannold N, Freundlich D, Kopelman D. Noninvasive thermal ablation of hepatocellular carcinoma by using magnetic resonance imaging-guided focused ultrasound. Gastroenterology 2004;127:S242-7.
8. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003;226:897-905.
9. Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynyen K, et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 2004;183:1713-9.
10. Stewart EA, Gedroyc WM, Tempany CM, Quade BJ, Inbar Y, Ehrenstein T, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003;189:48-54.
11. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med 1996;41:483-90.
12. Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002;99:290-300.
13. Sahin B, Emirzeoglu M, Uzun A, Incesu L, Bek Y, Bilgic S, et al. Unbiased estimation of the liver volume by the Cavalieri principle using magnetic resonance images. Eur J Radiol 2003;47:164-70.
14. Ishihara Y, Calderon A, Watanabe H, Okamoto K, Suzuki Y, Kuroda K. et al. A precise and fast temperature mapping using water proton chemical shift. Magn Reson Med 1995;34:814-23.
15. Leon-Villapalos J, Kaniorou-Larai M, Dziewulski P. Full Thickness abdominal burn following magnetic resonance guided focused ultrasound therapy. Burns 2005;31:1054-5.
16. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100-7.
17. Reid PC, Mukri F. Trends in number of hysterectomies performed in England for menorrhagia: examination of health episode statistics, 1989 to 2002-3. BMJ 2005;330:938-9.
18. Roth TM, Gustilo-Ashby T, Barber MD, Myers ER. Effects of race and clinical factors on short-term outcomes of abdominal myomectomy. Obstet Gynecol 2003;101:881-4.
19. Lethaby A, Vollenhoven B, Sowter M. Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review. BJOG 2002;109:1097-108.
20. Matta WH, Shaw RW, Nye M. Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin. Br J Obstet Gynaecol 1989;96:200-6.
21. Schriock ED. GnRH agonists. Clin Obstet Gynecol 1989;32:550-63.
22. Weeks AD, Wilkinson N, Arora DS, Duffy SR, Wells M, Walker JJ. Menopausal changes in the myometrium: an investigation using a GnRH agonist model. Int J Gynecol Pathol 1999;18:226-32.
23. Rutgers JL, Spong CY, Sinow R, Heiner J. Leuprolide acetate treatment and myoma arterial size. Obstet Gynecol 1995;86:386-8.